Latest Insider Transactions at Sunshine Biopharma, Inc. (SBFM)
This section provides a real-time view of insider transactions for Sunshine Biopharma, Inc. (SBFM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sunshine Biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sunshine Biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2024
|
Steve N. Slilaty Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+43.48%
|
$0
$0.1 P/Share
|
|
Feb 08
2024
|
Steve N. Slilaty Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+40.0%
|
$0
$0.1 P/Share
|
|
Nov 30
2022
|
Camille Sebaaly CFO/Secretary |
BUY
Open market or private purchase
|
Direct |
30,000
+14.67%
|
$0
$0.76 P/Share
|